View Author
pathway cancer phosphatase leukemia protein expression tumor activity kinase resistance hh pathway activation inhibitor tyrosine lmw-ptp hedgehog lucena mutation treatment phosphorylation patient level ptp 1b cd 45 malignancy growth receptor inhibition study target k 562 cells myeloid leukemia myeloid k 562 factor figure blood development mechanism chemoresistance result overexpression haematological malignancies haematological disease proliferation signal survival therapy addition speci / biochimica medulloblastoma queiroz myeloma domain lmwptp regulation pancreatic cd 45 expression ptdin chemotherapy inositol tc-ptp substrate vincristine lymphoma characteristic function pi 3k pathway heptp basal cell carcinoma leukemia kcs queiroz apoptosi metastatic gli 1 differentiation hematopoietic hh pathway inhibitors antagonist
4 Most Recent Publications
|
Knocking Down Low Molecular Weight Protein Tyrosine Phosphatase (LMW-PTP) Reverts Chemoresistance through Inactivation of Src and Bcr-Abl Proteins
(Article)
Ferreira, P.A. Ruela-de-Sousa, R.R. Queiroz, K.C.S. Souza, A.C.S. Milani, R. Pilli, R.A. Peppelenbosch, M.P. Hertog, J. den |
2012-09-05
|
|
Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors
(Article)
Queiroz, K.C.S. Spek, C.A. Peppelenbosch, M.P. |
2012-08-01
|
|
Hedgehog signaling maintains chemoresistance in myeloid leukemic cells
(Article)
Queiroz, K.C.S. Ruela-de-Sousa, R.R. Fuhler, G.M. Aberson, H.L. Ferreira, C.V. Peppelenbosch, M.P. Spek, C.A. |
2010-12-02
|
|
Reversible phosphorylation in haematological malignancies: Potential role for protein tyrosine phosphatases in treatment?
(Article)
Ruela-de-Sousa, R.R. Queiroz, K.C.S. Peppelenbosch, M.P. Fuhler, G.M. |
2010-08-09
|